Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Benxian Liu"'
Autor:
Kent Miner, Katja Labitzke, Benxian Liu, Paul Wang, Kathryn Henckels, Kevin Gaida, Robin Elliott, Jian Jeffrey Chen, Longbin Liu, Anh Leith, Esther Trueblood, Kelly Hensley, Xing-Zhong Xia, Oliver Homann, Brian Bennett, Mike Fiorino, John Whoriskey, Gang Yu, Sabine Escobar, Min Wong, Teresa L. Born, Alison Budelsky, Mike Comeau, Dirk Smith, Jonathan Phillips, James A. Johnston, Joseph G. McGivern, Kerstin Weikl, David Powers, Karl Kunzelmann, Deanna Mohn, Andreas Hochheimer, John K. Sullivan
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
There is an unmet need in severe asthma where approximately 40% of patients exhibit poor β-agonist responsiveness, suffer daily symptoms and show frequent exacerbations. Antagonists of the Ca2+-activated Cl− channel, TMEM16A, offers a new mechanis
Externí odkaz:
https://doaj.org/article/41d8cbf66f0741758aee1902a2f9ab21
Autor:
Hua Zhu Ke, Jin Wang, Jing Xu, Michael S. Ominsky, Murielle M. Véniant, Kelly S. Villasenor, Xiaodong Li, Benxian Liu, Narumol Chinookoswong, Rogely W. Boyce, Qing-Tian Niu, Philip Wong, Marina Stolina, Chun-Ya Han, Shanaka Stanislaus, Denise Dwyer, Michelle Chen, Frank Asuncion
Publikováno v:
Journal of Bone and Mineral Research. 32:834-845
Results of prior studies suggest that fibroblast growth factor 21 (FGF21) may be involved in bone turnover and in the actions of peroxisome proliferator-activated receptor (PPAR) α and γ in mice. We have conducted independent studies to examine the
Autor:
Kevin Gaida, Xuxia Zhang, Robin Elliott, Benxian Liu, Andrea Itano, Cynthia Park, Justin K. Murray, Colin V. Gegg, Jennifer Aral, Les P. Miranda, Joseph G. McGivern, Hongyan Li, Anne Colombero, E. Allen Sickmier, Kevin Salyers, Michael Stenkilsson, Jonathan Werner, Steven Yu, Mark J. Rose, John K. Sullivan, Yi-Xin Qian, Peter Miu, Kristin L. Andrews
Publikováno v:
Journal of Medicinal Chemistry. 58:6784-6802
To realize the medicinal potential of peptide toxins, naturally occurring disulfide-rich peptides, as ion channel antagonists, more efficient pharmaceutical optimization technologies must be developed. Here, we show that the therapeutic properties of
Autor:
Xiaodong, Li, Shanaka, Stanislaus, Frank, Asuncion, Qing-Tian, Niu, Narumol, Chinookoswong, Kelly, Villasenor, Jin, Wang, Philip, Wong, Rogely, Boyce, Denise, Dwyer, Chun-Ya, Han, Michelle M, Chen, Benxian, Liu, Marina, Stolina, Hua Zhu, Ke, Michael S, Ominsky, Murielle M, Véniant, Jing, Xu
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 32(4)
Results of prior studies suggest that fibroblast growth factor 21 (FGF21) may be involved in bone turnover and in the actions of peroxisome proliferator-activated receptor (PPAR) α and γ in mice. We have conducted independent studies to examine the
Autor:
Murray, Justin K., Yi-Xin Qian, Benxian Liu, Elliott, Robin, Aral, Jennifer, Park, Cynthia, Xuxia Zhang, Stenkilsson, Michael, Salyers, Kevin, Rose, Mark, Hongyan Li, Yu, Steven, Andrews, Kristin L., Colombero, Anne, Werner, Jonathan, Gaida, Kevin, Sickmier, E. Allen, Miu, Peter, Itano, Andrea, McGivern, Joseph
Publikováno v:
Journal of Medicinal Chemistry; Sep2015, Vol. 58 Issue 17, p6784-6802, 19p